Literature DB >> 23955097

Nuclear localization of huntingtin during spermatogenesis.

Wooseok Im1, Jinyoung Chung, Soon-Tae Lee, Kon Chu, Min-Wook Kim, Manho Kim.   

Abstract

Huntingtin is a ubiquitous cytoplasmic protein. Mutant huntingtin causes Huntington's disease and its intranuclear inclusion is associated with cytotoxicity. Nuclear localization of normal huntingtin is detected in the oocyte up to 2.5 days post coitum. Therefore, huntingtin is expected to reside in the nucleus even before fertilization. The present study determined normal huntingtin distribution during spermatogenesis. Testicles from an adult male Sprague-Dawley rat were stained with anti-huntingtin antibody and nuclear counterstaining was performed with 4',6-diamidino-2-phenylindole. Concerning nuclear localization, huntingtin was detected in the spermatids, whereas predominant cytoplasmic localization of it was evident in the spermatogonia. Between the primary and secondary spermatocytes, huntingtin appeared to be delocalized in the nuclei when meiosis occurred. The findings provide evidence that normal huntingtin is transported to the nuclear compartment during the meiotic stage of spermatogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23955097     DOI: 10.1007/s10072-013-1515-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  10 in total

1.  Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.

Authors:  F C Nucifora ; M Sasaki; M F Peters; H Huang; J K Cooper; M Yamada; H Takahashi; S Tsuji; J Troncoso; V L Dawson; T M Dawson; C A Ross
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

2.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

Authors:  J S Steffan; A Kazantsev; O Spasic-Boskovic; M Greenwald; Y Z Zhu; H Gohler; E E Wanker; G P Bates; D E Housman; L M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription.

Authors:  Kimberly B Kegel; Alison R Meloni; Yong Yi; Yun J Kim; Erin Doyle; Benjamin G Cuiffo; Ellen Sapp; Yumei Wang; Zheng-Hong Qin; J Don Chen; Joseph R Nevins; Neil Aronin; Marian DiFiglia
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

4.  Huntingtin is localized in the nucleus during preimplanatation embryo development in mice.

Authors:  Sung-Jin Jeong; Manho Kim; Keun-A Chang; Hye-Sun Kim; Cheol-Hyoung Park; Yoo-Hun Suh
Journal:  Int J Dev Neurosci       Date:  2005-11-14       Impact factor: 2.457

Review 5.  Huntingtin as an essential integrator of intracellular vesicular trafficking.

Authors:  Juliane P Caviston; Erika L F Holzbaur
Journal:  Trends Cell Biol       Date:  2009-03-05       Impact factor: 20.808

6.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

7.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

8.  Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.

Authors:  N Ahmad Aziz; Martine J van Belzen; Ilona D Coops; René D M Belfroid; Raymund A C Roos
Journal:  Eur J Med Genet       Date:  2011-04-23       Impact factor: 2.708

9.  Huntington disease expansion mutations in humans can occur before meiosis is completed.

Authors:  Song-Ro Yoon; Louis Dubeau; Margot de Young; Nancy S Wexler; Norman Arnheim
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

10.  Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.

Authors:  C Zuccato; A Ciammola; D Rigamonti; B R Leavitt; D Goffredo; L Conti; M E MacDonald; R M Friedlander; V Silani; M R Hayden; T Timmusk; S Sipione; E Cattaneo
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728

  10 in total
  1 in total

Review 1.  Spermatozoan Metabolism as a Non-Traditional Model for the Study of Huntington's Disease.

Authors:  Meghan Lawlor; Michal Zigo; Karl Kerns; In Ki Cho; Charles A Easley Iv; Peter Sutovsky
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.